Browse our 650+ Publications​

Latest Publications

Antimalarial antibody repertoire defined by plasma IG proteomics and single B cell IG sequencing

Coelho CH., et al.
JCI Insight
October 2020
Authors and Affiliates
Camila H Coelho 1, Steven T Nadakal 1, Patricia A Gonzales Hurtado 1, Robert Morrison 1, Jacob D Galson 2, Jillian Neal 1, Yimin Wu 3, C Richter King 3, Virginia Price 3, Kazutoyo Miura 4, Sharon Wong-Madden 1, Justin Ya Dortichamou 1, David L Narum 1, Nicholas J MacDonald 1, Maryonne Snow-Smith 1, Marissa Vignali 5, Justin J Taylor 6, Marie-Paule Lefranc 7, Johannes Trück 8, Carole A Long 4, Issaka Sagara 9, Michal Fried 1, Patrick E Duffy 1; 1 Laboratory for Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Rockville, United States of America. 2 Department of Pediatrics, University Children's Hospital Zürich, Zürich, Switzerland. 3 PATH's Malaria Vaccine Initiative, Washington DC, United States of America. 4 Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, NIH, Rockville, United States of America. 5 Adaptive Biotechnologies, Inc., Seattle, United States of America. 6 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, United States of America. 7 Institut de Génétique Humaine, Université Montpellier 2, Montpellier, France. 8 Department of Immunology, University Children's Hospital Zürich, Zürich, Switzerland. 9 Malaria Research and Training Center, University of Bamako, Bamako, Mali.

Circulating α4β7+ Memory T Cells in Pediatric IBD Patients Express a Polyclonal T Cell Receptor Repertoire

Gamliel A., et al.
Clinical and Experimental Gastroenterology
October 2020
Authors and Affiliates
Adir Gamliel 1,2, Lael Werner 1,2, Marina Pinsker 1,3, Naomi Salamon 1, Batia Weiss 1,2, Dror S Shouval 1,2; 1 Pediatric Gastroenterology Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Ramat Gan, Israel 2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 3 Institute of Nanotechnology and Advanced Materials, Bar Ilan University, Ramat Gan, Israel

Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer

Braun MW., et al.
Journal for ImmunoTherapy of Cancer
October 2020
Authors and Affiliates
Mitchell W Braun 1, Haitham Abdelhakim 2, Meizhang Li 1, Stephen Hyter 1, Ziyan Pessetto 1, Devin C Koestler 3, Harsh B Pathak 1,4, Neil Dunavin 5,6, Andrew K Godwin 7,4; 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. 2 Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA. 3 Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA. 4 The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, USA. 5 UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. 6 Division on Hematology and BMT, UCSF, San Francisco, California, USA. 7 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA agodwin@kumc.edu.

T cell repertoire analysis suggest a prominent bystander response in human cardiac allograft vasculopathy

Habal MV., et al.
American Journal of Transplantation
October 2020
Authors and Affiliates
Marlena V Habal 1,2, April M I Miller 1,3, Samhita Rao 1, Sijie Lin 1,4, Aleksandar Obradovic 1, Mohsen Khosravi-Maharlooei 1, Sarah See 1, Poulomi Roy 1, Shihab Ronzon 1, Siu-Hong Ho 1,5, Charles Marboe 6, Yoshifumi Naka 7, Koji Takeda 7, Susan Restaino 2, Arnold Han 1, Donna Mancini 8, Michael Givertz 9, Joren C Madsen 10,11, Megan Sykes 1, Linda Addonizio 12, Maryjane Farr 2, Emmanuel Zorn 1; 1 Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA. 2 Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA. 3 Case Western Reserve University School of Medicine, NY, USA. 4 Stanford University, Department of Genetics, NY, USA. 5 Cytek Biosciences, NY, USA. 6 Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA. 7 Department of Surgery, Division of Cardiothoracic Surgery, Columbia University Irving Medical Center, New York, NY, USA. 8 Department of Medicine, Mount Sinai Hospital, Icahn School of Medicine, New York, NY, USA. 9 Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 10 Center for Transplantation Science, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 11 Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 12 Department of Pediatrics, Division of Pediatric Cardiology, Columbia University Irving Medical Center, New York, NY, USA.

Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports

Rojansky R., et al.
Diagnostic Pathology
October 2020
Authors and Affiliates
Rebecca Rojansky 1, Sebastian Fernandez-Pol 1, Erica Wang 2, Kerri E Rieger 1,2, Roberto A Novoa 1,2, James L Zehnder 1,3, Christian A Kunder 1, Youn H Kim 2,4, Michael S Khodadoust 2,4, Ryanne A Brown 5,6,7; 1 Department of Pathology, Stanford Medicine, Stanford, CA, 94305, USA. 2 Department of Dermatology, Stanford Medicine, Stanford, CA, 94305, USA. 3 Division of Hematology, Department of Medicine, Stanford Medicine, Stanford, CA, 94305, USA. 4 Division of Oncology, Department of Medicine, Stanford Medicine, Stanford, CA, 94305, USA. 5 Department of Pathology, Stanford Medicine, Stanford, CA, 94305, USA. rbrown85@stanford.edu. 6 Department of Dermatology, Stanford Medicine, Stanford, CA, 94305, USA. rbrown85@stanford.edu. 7 Department of Pathology, Veterans Affairs Palo Alto Health Care System, 3375 Hillview Ave, Room 1821, Palo Alto, CA, 94304-1204, USA. rbrown85@stanford.edu.

CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

Lai AY., et al.
Journal for ImmunoTherapy of Cancer
October 2020
Authors and Affiliates
Anne Y Lai 1, Jessica A Sorrentino 2, Konstantin H Dragnev 3, Jared M Weiss 4, Taofeek K Owonikoko 5, Julie A Rytlewski 6, Jill Hood 6, Zhao Yang 1, Rajesh K Malik 1, Jay C Strum 1, Patrick J Roberts 1; 1 Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA. 2 Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA jsorrentino@g1therapeutics.com. 3 Department of Hematology and Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. 4 Division of Hematology and Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA. 5 Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA. 6 Life Sciences Research, Adaptive Biotechnologies Corp, Seattle, Washington, USA.

mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

Cafri G., et al.
JCI
Journal of Clinical Investigation
October 2020
Authors and Affiliates
Gal Cafri 1 2, Jared J Gartner 1, Tal Zaks 3, Kristen Hopson 3, Noam Levin 1, Biman C Paria 1, Maria R Parkhurst 1, Rami Yossef 1, Frank J Lowery 1, Mohammad S Jafferji 1, Todd D Prickett 1, Stephanie L Goff 1, Christine T McGowan 1, Samantha Seitter 1, Mackenzie L Shindorf 1, Anup Parikh 1, Praveen D Chatani 1, Paul F Robbins 1, Steven A Rosenberg 1; 1 Surgery Branch, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA. 2 Sheba Medical Center, Ramat Gan, Israel. 3 Moderna Inc., Cambridge, Massachusetts, USA.

Analysis of the Heterogeneity of CD4+CD25+ T Cell TCR β CDR3 Repertoires in Breast Tumor Tissues, Lung Metastatic Tissues, and Spleens from 4T1 Tumor-Bearing BALB/c Mice

Zhang T,. et al.
Journal of Immunology Research
October 2020
Authors and Affiliates
Teng Zhang 1 2, Fangfang Duan 2, Danhua Su 2, Long Ma 2, Jiezuan Yang 3, Bin Shi 4, Xiaoyan He 2, Rui Ma 2, Suhong Sun 1, Xinsheng Yao 2; 1 Department of Breast Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China 2 Department of Immunology, Research Center for Medicine & Biology, Innovation & Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, Guizhou, China 3 Department of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 4 Department of Laboratory Medicine, Zunyi Medical University, Zunyi, Guizhou, China

Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis

Sanz-Pamplona R., et al.
PLOS Medicine
September 2020
Authors and Affiliates
Rebeca Sanz-Pamplona 1,2,3, Marilena Melas 4, Asaf Maoz 5, Stephanie L Schmit 6, Hedy Rennert 7, Flavio Lejbkowicz 7, Joel K Greenson 8, Xavier Sanjuan 9, Maria Lopez-Zambrano 9, M Henar Alonso 1,2,3 10, Chenxu Qu 11, Kevin J McDonnell 11, Gregory E Idos 11, Marissa Vignali 12, Ryan Emerson 12, Paul Fields 12, Elisabet Guinó 1,2,3, Cristina Santos 1,2,13, Ramon Salazar 1,2,13, Harlan S Robins 12,14, Gad Rennert 7, Stephen B Gruber 11, Victor Moreno 1,2,3,10; 1 Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain. 2 ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. 3 Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain. 4 Nationwide Children's Hospital, Columbus, Ohio, United States of America. 5 Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America. 6 H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America. 7 Carmel Medical Center, and Technion, Haifa, Israel. 8 University of Michigan Medical School, Ann Arbor, Michigan, United States of America. 9 University Hospital Bellvitge (HUB-IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. 10 Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain. 11 City of Hope National Medical Center, Duarte, California, United States of America. 12 Adaptive Biotechnologies, Seattle, Washington, United States of America. 13 Consortium for Biomedical Research in Oncology (CIBERONC), Spain. 14 Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Serial Assessment of Circulating T lymphocyte Phenotype and Receptor Repertoire During Treatment of Non-Muscle Invasive Bladder Cancer with Adoptive T Cell Immunotherapy

Wang X., et al.
September 2020
Authors and Affiliates
Xiaoli Wang 1, Guoliang Qiao 1, Ni Jiang 1, Michael A Morse 2, Xinna Zhou 1, Shuo Wang 1, Jiangping Wu 1, Yuguang Song 1, Yanjie Zhao 1, Lei Zhou 1, Yanhua Yuan 1, Amy Hobeika 2, Jun Ren 1, Herbert Kim Lyerly 1; 1 Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China 2 Duke University Medical Center, Durham, NC, USA
Previous Next